Editor Mohit Manghnani
Profile| Send Message
Gameplan For The Coming Week - Cramer's Mad Money (2/17/15)
Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Friday, February 13.Palo Alto Networks (NYSE:PANW): Cramer thinks that the stock is good, CyberArk (NASDAQ:CYBR)is better.
in this security market will double + every qt
Achillion, Gilead drug cocktail cures hepatitis C in six weeks
Mon Feb 9, 2015 7:45am EST
The combination of Sovaldi and Achillion's ACH-3102 continues to show 100% results, with this level of effectiveness, the treatment could eventually rival offerings from Gilead and AbbVie Inc to fight the liver-destroying virus.
If the combination of Sovaldi and Achillion's ACH-3102 continues to show this level of effectiveness, the treatment could eventually rival offerings from Gilead and AbbVie Inc to fight the liver-destroying virus.
Achillion's data represents the shortest duration and highest response achieved to date with any two-drug, direct-acting antiviral regimen for hep C, Chief Executive Milind Deshpande said in a statement.
been doing DD looks good- got in
There will be no pullback friend, News came out after 6:00 on Friday, Millions are learning of news now, look for big gains Monday Premarket and into the bell, only pullback will be around 10:00 am after trading starts.
google it or link on stocktwits
Juno has partnered with world leading medical and research organizations to advance a broad pipelineof novel immunotherapies, including the Fred Hutchinson Cancer Research Center, or FHCRC, the Mmorial Sloan Kettering Cancer Center, or MSK, and the Seattle Children’s Research Institute, or SCRI
you forgot buyout target !!
Sentiment: Strong Buy